» Articles » PMID: 9450510

The Rising Global Burden of Diabetes and Its Complications: Estimates and Projections to the Year 2010

Overview
Journal Diabet Med
Specialty Endocrinology
Date 1997 Jan 1
PMID 9450510
Citations 353
Authors
Affiliations
Soon will be listed here.
Abstract

Prevention and control programmes are needed to stem the rising epidemic of diabetes and its complications. However, these will not occur unless governments and public health planners are aware of the potential problem. Using published prevalence rates for NIDDM in different populations, and the current and projected age distributions, worldwide prevalence of NIDDM was estimated for 1995 and 1997, and well as projections for 2000 and 2010. Prevalence rates used for projections were chosen to reflect changes in lifestyle with economic development. The global prevalence of IDDM was estimated using published incidence rates and population figures, incorporating the likely survival time from development of IDDM. Data on diabetes complications are also summarised but no attempt has been made to extrapolate to a global estimated. In 1997, an estimated 124 million people worldwide have diabetes, 97% of these having NIDDM. By the year 2010 the total number of people with diabetes is projected to reach 221 million. The regions with the greatest potential increases are Asia and Africa, where diabetes rates could rise to 2 or 3 times those experienced today. With improvements in the treatment of IDDM, the prevalence of this form of diabetes is likely to increase as more people survive for longer after diagnosis. Increases in complications will undoubtedly follow increasing prevalence of diabetes, but population-based studies using standardised methods of diagnosis are required before reliable estimates of the extent of the problem can be made. It is hoped that the information provided in this report, and others like it, will act as an incentive to initiate or improve local diabetes monitoring and prevention strategies.

Citing Articles

Rising mortality rates linked to type-2 diabetes and obesity in the United States: An observational analysis from 1999 to 2022.

Ahmed M, Nofal A, Shafiq A, Javaid H, Ahsan A, Nadeem Z J Diabetes Investig. 2024; 16(3):492-500.

PMID: 39698779 PMC: 11871392. DOI: 10.1111/jdi.14386.


Anti-oxidative and immunological role of Cyclocarya paliurus polysaccharide on the liver injury of diabetic rats.

Xichao X, Shipeng X, Guoying S, Bin L, Huiping W, Ju Q J Tradit Chin Med. 2024; 44(6):1146-1152.

PMID: 39617700 PMC: 11589557. DOI: 10.19852/j.cnki.jtcm.2024.06.005.


Acceptability of community health worker and peer supported interventions for ethnic minorities with type 2 diabetes: a qualitative systematic review.

Grant V, Litchfield I Front Clin Diabetes Healthc. 2024; 5:1306199.

PMID: 38836261 PMC: 11148349. DOI: 10.3389/fcdhc.2024.1306199.


A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries.

Butt M, Ong S, Rafiq A, Kalam M, Sajjad A, Abdullah M J Pharm Policy Pract. 2024; 17(1):2322107.

PMID: 38650677 PMC: 11034455. DOI: 10.1080/20523211.2024.2322107.


Healthcare Utilization and Its Correlates in Comorbid Type 2 Diabetes Mellitus and Generalized Anxiety Disorder.

Huang C, Lin C, Liu T, Lin P, Chu C, Wang J Psychiatr Q. 2024; 95(2):233-252.

PMID: 38639873 DOI: 10.1007/s11126-024-10072-z.